# Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Therapeutic Failure

> **NCT07455721** · — · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 1200 (estimated)

## Conditions studied

- Adenomyosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07455721
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-09
- **Primary completion:** 2027-12-09
- **Final completion:** 2028-06-30
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07455721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07455721, "Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Therapeutic Failure". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07455721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*